ATR and PARP1 — Drug Target
All drugs that target ATR and PARP1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Serine/threonine kinase inhibitor and PARP inhibitor
Phase 1 pipeline (1)
- Administration of ceralasertib and olaparib · AstraZeneca · Serine/threonine kinase inhibitor and PARP inhibitor · Oncology
PARP inhibitor